DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

Acton, Massachusetts-based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top ...

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...

Dexcom (DXCM) has received a new Buy rating, initiated by Wells Fargo analyst, Larry Biegelsen.Stay Ahead of the Market:Discover outperforming ...

Insulet announces the launch of Omnipod 5 in five more countries in Europe, Italy, Denmark, Finland, Norway and Sweden.

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Unless you’re an advocate for health tech or a diabetic like me, you may not have heard of Dexcom or Abbott, the two companies that form an oligopoly in the CGM space. Yet, you’re probably ...

DexCom recently launched Stelo CGM, its first over-the-counter glucose sensor targeting non-insulin using adults with Type 2 diabetes or prediabetes in the United States. This move expands DexCom ...